Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
Clinical trial NCT06833723 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06833723
- Sponsor
- Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-17
- Primary completion
- 2025-12-17
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.